Beijing Wujiahe Gene Technology Co.
Latest round
- Series A
Last raised
- Sep 2021
Total raised
- Undisclosed
Investors
- 4
About Beijing Wujiahe Gene Technology Co.
, Ltd is a gene therapy medicine R&D and its related services company that focuses on research and developing virus vector. It was founded by its parent company, Beijing Fiveplus Molecular Medicine Institute. Its core technical team come from parent company, who has over 20 years experience of gene therapy virus vector research and was involved in a number of nation-level project, and also joined the draft of Quality standard of Natioanl AAV vector gene medicine. It has over 2600 square meters of experiment area and a 600 square meters GMP level pilot test area, 1000 square meters of R&D lab. The company offers an one-stop contract development manufacture organization (CDMO) service from molecular design, process exploration to clinical test medicine manufacturing and quality evaluation. It provided herpes simplex virus(HSV)manufacturing to client and has already been approved for clinical trail by NMPA in Jul, 2019.
Who invested in Beijing Wujiahe Gene Technology Co.
4 investors across 2 rounds
See all investors in Beijing Wujiahe Gene Technology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Beijing Wujiahe Gene Technology Co.
Who invested in Beijing Wujiahe Gene Technology Co.?
Beijing Wujiahe Gene Technology Co. has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beijing Wujiahe Gene Technology Co. raised?
Beijing Wujiahe Gene Technology Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Beijing Wujiahe Gene Technology Co. last raise money?
Beijing Wujiahe Gene Technology Co.'s most recent round on record is a Series A, in Sep 2021.
What does Beijing Wujiahe Gene Technology Co. do?
, Ltd is a gene therapy medicine R&D and its related services company that focuses on research and developing virus vector.
Where is Beijing Wujiahe Gene Technology Co. headquartered?
Beijing Wujiahe Gene Technology Co. is headquartered in Beijing, China.
Which VCs invest in companies like Beijing Wujiahe Gene Technology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Beijing Wujiahe Gene Technology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Beijing Wujiahe Gene Technology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.